Most Popular
-
1
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
2
S. Korea not to attend Sado mine memorial: foreign ministry
-
3
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
-
4
[Weekender] Korea's traditional sauce culture gains global recognition
![[Weekender] Korea's traditional sauce culture gains global recognition](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050153_0.jpg&u=20241123224317)
-
5
BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'
![[Weekender] Korea's traditional sauce culture gains global recognition](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050153_0.jpg&u=20241123224317)
Shinhan Investment partners UK advisory firm to support bio firms’ overseas entry
By Choi Jae-heePublished : Nov. 15, 2021 - 14:00
Shinhan Investment said Monday it has signed a memorandum of understanding with PharmaVentures, a UK-based leading advisory firm providing whose main clients are health care life science companies, to diverse its investment banking services.
Under the partnership agreement, the two companies will boost cooperation in supporting South Korean biotech and pharmaceutical companies to advance to the global stage, while arranging international firms’ investments in the domestic health care market.
“We will provide differentiated IB services to help large and midsized bio firms to successfully make inroads into the global market,” said Jung Keun-soo, vice president and managing director of Shinhan Investment’s global investment banking division.
“In the coming year, (Shinhan Investment) will continue to carry out meaningful capital markets businesses to boost future growth industries.”
Founded in 1992, PharmaVentures handled more than 1,000 cases of mergers, acquisitions and joint venture activities for companies worldwide.
Under the partnership agreement, the two companies will boost cooperation in supporting South Korean biotech and pharmaceutical companies to advance to the global stage, while arranging international firms’ investments in the domestic health care market.
“We will provide differentiated IB services to help large and midsized bio firms to successfully make inroads into the global market,” said Jung Keun-soo, vice president and managing director of Shinhan Investment’s global investment banking division.
“In the coming year, (Shinhan Investment) will continue to carry out meaningful capital markets businesses to boost future growth industries.”
Founded in 1992, PharmaVentures handled more than 1,000 cases of mergers, acquisitions and joint venture activities for companies worldwide.
![[More than APT] Residents, architects together design homes](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/11/24/20241124050036_0.jpg&u=)
